Other names: Simponi, Simponi Aria
Categories: Prescription Medication
Description:
Golimumab (Simponi, Simponi Aria) is a TNF-alpha inhibitor biologic DMARD used for moderate to severe rheumatoid arthritis, usually with methotrexate. It comes as a monthly subcutaneous injection or an IV infusion every 8 weeks, making it one of the more convenient options among TNF blockers. Golimumab helps reduce pain, swelling, and long-term joint damage in patients who haven’t responded well to conventional DMARDs. Side effects include injection or infusion reactions and an increased risk of infections such as tuberculosis or hepatitis, so screening and regular monitoring are required. Overall, it is an effective and relatively low-frequency dosing option for RA.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the effectiveness of Golimumab as a treatment for Rheumatoid Arthritis. The author has not provided a review or rating for this treatment. Therefore, it is not possible to summarize the effectiveness of Golimumab against Rheumatoid Arthritis due to the lack of available data and user feedback.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
